Physician profile
Vivek Jain
NPI 1245249085
$14,045.01
in general payments reported to CMS, 2019-2025
18 companies · $1,181 in 2025
The $1,181 reported for 2025 was more than what 80% of Critical Care Medicine (Internal Medicine) providers received nationally (typical 2025 total: $189).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,376 · 2020: $5,160 · 2021: $25.04 · 2022: $604 · 2023: $4,569 · 2024: $1,131 · 2025: $1,181.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,250 · Food and Beverage: $3,248 · Education: $358 · Travel and Lodging: $24.80.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,250.00 |
| Food and Beverage | $3,247.91 |
| Education | $357.77 |
| Travel and Lodging | $24.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Respicardia, INC. | $5,127.66 | 2019-2020 | |
| Idorsia Pharmaceuticals US INC | $3,888.68 | 2023 | Quviviq |
| Inspire Medical Systems, INC. | $1,812.16 | 2019-2025 | Inspire |
| Jazz Pharmaceuticals INC. | $843.57 | 2019-2025 | |
| Itamar Medical INC | $587.72 | 2022-2025 | Watchpatone |
| Harmony Biosciences LLC | $430.71 | 2020-2025 | Wakix |
| Axsome Therapeutics, INC. | $305.21 | 2023-2025 | Sunosi |
| Avadel Cns Pharmaceuticals, LLC | $227.85 | 2023-2025 | Lumryz |
| Boehringer Ingelheim Pharmaceuticals, INC. | $188.17 | 2019 | |
| Grifols USA, LLC | $133.10 | 2024 | Prolastin-C Liquid |
| Mylan Specialty L.P. | $118.91 | 2020 | |
| Philips North America LLC | $96.23 | 2019 | |
| Lilly USA, LLC | $96.05 | 2025 | Zepbound |
| Insmed, INC. | $95.55 | 2019 | |
| Fisher & Paykel Healthcare INC | $35.49 | 2025 | Fisher & Paykel Healthcare |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $29.57 | 2025 | |
| Glaxosmithkline, LLC. | $15.39 | 2022 | |
| Carl Zeiss Meditec, INC. | $12.99 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vivek Jain listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.